SB
WST icon

Strategic Blueprint’s West Pharmaceutical WST Stock Holding History

Strategic Blueprint’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-65
Closed -$23K – 1334
2021
Q2 		$23K Buy
+65
New +$21.5K ﹤0.01% 786

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Strategic Blueprint's WST Position: Q3 2021 in Review

Strategic Blueprint sold out of West Pharmaceutical (WST) in Q3 2021, closing a stake of 65 shares — an estimated $23K sold.

Strategic Blueprint first reported a position in WST in Q2 2021 and held it in 1 quarter. The position peaked at $23K in Q2 2021. 669 funds tracked by Wall St. Rank hold WST as of Q3 2021.

  • Strategic Blueprint reported no remaining West Pharmaceutical position as of Q3 2021 after selling out during the quarter.
  • Strategic Blueprint sold 65 West Pharmaceutical shares in Q3 2021, an estimated $23K.
  • Strategic Blueprint first reported a position in West Pharmaceutical in Q2 2021 and held it in 1 quarter.
  • Strategic Blueprint's West Pharmaceutical position peaked at $23K in Q2 2021.
  • 669 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2021.

Based on Strategic Blueprint's 13F filing for Q3 2021, filed 12 Nov 2021.